Dongkoo Bio&Pharma

DongKoo Bio&Pharma is an innovative bio and pharmaceutical company focused on developing and manufacturing a range of healthcare solutions. Its core offerings include prescription medicines with a strong presence in dermatology and urology, alongside an expanding portfolio in other medical specialties. The company also operates a Contract Manufacturing Organization (CMO) business, leveraging its manufacturing capabilities, and actively develops bio-industry products, notably stem cell-based healthcare solutions such as the cosmeceutical brand CELL BLOOM, which utilizes patented 3D Stem Cell Conditioned Media.

Founded in 1970 as Dongkoo Pharmaceutical, the company initially concentrated on traditional pharmaceutical products. Over decades, it cultivated expertise in specific therapeutic areas like dermatology, achieving market leadership. A pivotal evolution occurred in 2014 with the change to DongKoo Bio&Pharma, signifying a strategic pivot towards biotechnology and stem cell research, exemplified by the introduction of stem cell extracting kits and related medical technologies. This transformation broadened its scope beyond conventional drug development.

DongKoo Bio&Pharma serves a wide array of customers, from medical professionals and patients benefiting from its prescription drugs to consumers utilizing its advanced cosmeceutical products. The company envisions itself as a total healthcare leader, dedicated to improving human health and happiness. Guided by principles of responsibility, compassion, and respect for life, it actively explores both established and new markets to foster advancements in human well-being.